OKED-CAS: Transformative Health Networks

Research Output 2011 2018

Filter
Article
2018
8 Citations (Scopus)

Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes

Domenyuk, V., Gatalica, Z., Santhanam, R., Wei, X., Stark, A., Kennedy, P., Toussaint, B., Levenberg, S., Wang, J., Xiao, N., Greil, R., Rinnerthaler, G., Gampenrieder, S. P., Heimberger, A. B., Berry, D. A., Barker, A., Quackenbush, J., Marshall, J. L., Poste, G., Vacirca, J. L. & 9 others, Vidal, G. A., Schwartzberg, L. S., Halbert, D. D., Voss, A., Magee, D., Miglarese, M. R., Famulok, M., Mayer, G. & Spetzler, D., Dec 1 2018, In : Nature Communications. 9, 1, 1219.

Research output: Contribution to journalArticle

breast
cancer
Breast Neoplasms
Ligands
ligands
2017
4 Citations (Scopus)

The path forward: 2015 International Children's Tumor Foundation conference on neurofibromatosis type 1, type 2, and schwannomatosis

Blakeley, J. O., Bakker, A., Barker, A., Clapp, W., Ferner, R., Fisher, M. J., Giovannini, M., Gutmann, D. H., Karajannis, M. A., Kissil, J. L., Legius, E., Lloyd, A. C., Packer, R. J., Ramesh, V., Riccardi, V. M., Stevenson, D. A., Ullrich, N. J., Upadhyaya, M. & Stemmer-Rachamimov, A., Jun 1 2017, In : American Journal of Medical Genetics, Part A. 173, 6, p. 1714-1721 8 p.

Research output: Contribution to journalArticle

Neurofibromatosis 2
Neurofibromatosis 1
Neurofibromatoses
Neoplasms
Drug Industry
2015
13 Citations (Scopus)
Biomarkers
Research
Precision Medicine
Practice Guidelines
Private Sector
2014
Biomarkers
Medicine
10 Citations (Scopus)

The National Biomarker Development Alliance accelerating the translation of biomarkers to the clinic

Barker, A., Compton, C. & Poste, G., Jul 1 2014, In : Biomarkers in Medicine. 8, 6, p. 873-876 4 p.

Research output: Contribution to journalArticle

Precision Medicine
Translational Medical Research
Biomarkers
19 Citations (Scopus)

Turning the tide against cancer through sustained medical innovation: The pathway to progress

Abernethy, A., Abrahams, E., Barker, A., Buetow, K., Burkholder, R., Dalton, W. S., Foti, M., Frueh, F., Gaynor, R. B., Kean, M., Khan, Z., Lessor, T., Lichtenfeld, J. L., Mendelsohn, J. & Van'T Veer, L., 2014, In : Clinical Cancer Research. 20, 5, p. 1081-1086 6 p.

Research output: Contribution to journalArticle

Neoplasms
Research
Costs and Cost Analysis
Comparative Effectiveness Research
Learning
2013
43 Citations (Scopus)

AACR cancer progress report 2013

Sawyers, C. L., Abate-Shen, C., Anderson, K. C., Barker, A., Baselga, J., Berger, N. A., Foti, M., Jemal, A., Lawrence, T. S., Li, C. I., Mardis, E. R., Neumann, P. J., Pardoll, D. M., Prendergast, G. C., Reed, J. C. & Weiner, G. J., Oct 15 2013, In : Clinical Cancer Research. 19, SUPPL.1

Research output: Contribution to journalArticle

Neoplasms
Biomedical Research
National Institutes of Health (U.S.)
Federal Government
Economics
2012
11 Citations (Scopus)

Adaptive trials in the neoadjuvant setting: A model to safely tailor care while accelerating drug development

Yee, D., Haddad, T., Albain, K., Barker, A., Benz, C., Boughey, J., Buxton, M., Chien, A. J., DeMichele, A., Dilts, D., Elias, A., Haluska, P., Hogarth, M., Hu, A., Hytlon, N., Kaplan, H. G., Kelloff, G. G., Khan, Q., Lang, J., Leyland-Jones, B. & 18 others, Liu, M., Nanda, R., Northfelt, D., Olopade, O. I., Park, J., Parker, B., Parkinson, D., Pearson-White, S., Perlmutter, J., Pusztai, L., Symmans, F., Rugo, H., Tripathy, D., Wallace, A., Wholley, D., Van't Veer, L., Berry, D. A. & Esserman, L., Dec 20 2012, In : Journal of Clinical Oncology. 30, 36, p. 4584-4586 3 p.

Research output: Contribution to journalArticle

2011
2 Citations (Scopus)

Q&A: Anna Barker on the cancer genome atlas.

Barker, A., Aug 2011, In : Cancer Discovery. 1, 3, p. 193 1 p.

Research output: Contribution to journalArticle

Atlases
Human Genome
Genome
Neoplasms